Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients
暂无分享,去创建一个
A. Adamou | M. Inbar | N. Ben-Baruch | A. Sulkes | I. Hardan | S. Rizel | S. Stemmer | H. Brenner | M. Gottfried | Y. Merrick | Y. Cohen | R. Pfeffer | H. Raz